Genomic analysis of multiple myeloma using targeted capture sequencing in the Japanese cohort-Reference-Cited by-同舟云学术

Genomic analysis of multiple myeloma using targeted capture sequencing in the Japanese cohort

Published:2020-05-09 Issue:5 Volume:191 Page:755-763
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br. J. Haematol.

Author:

Kanamori Takashi¹²^ORCID,Sanada Masashi²,Ri Masaki¹^ORCID,Ueno Hiroo³,Nishijima Dai²,Yasuda Takahiko²,Tachita Takuto¹,Narita Tomoko¹,Kusumoto Shigeru¹,Inagaki Atsushi⁴,Ishihara Rei⁵,Murakami Yuki⁵,Kobayashi Nobuhiko⁶,Shiozawa Yusuke³⁷,Yoshida Kenichi³,Nakagawa Masahiro M.³,Nannya Yasuhito³,Shiraishi Yuichi⁸,Chiba Kenichi⁹,Tanaka Hiroko⁹,Miyano Satoru⁹,Horibe Keizo²,Handa Hiroshi⁵^ORCID,Ogawa Seishi³¹⁰¹¹,Iida Shinsuke¹

Affiliation:

1. Department of Hematology and Oncology Nagoya City University Graduate School of Medical Sciences Japan

2. Clinical Research Center National Hospital Organization Nagoya Medical Center Japan

3. Department of Pathology and Tumor Biology Kyoto University Kyoto Japan

4. Department of Hematology and Oncology Nagoya City West Medical Center Japan

5. Department of Laboratory Science Gunma University Graduate School of Health Science Japan

6. Department of Hematology Gunma University Graduate School of Medicine Japan

7. Department of Pediatrics Graduate School of Medicine The University of Tokyo Japan

8. Division of Cellular Signaling National Cancer Center Research Institute Japan

9. Human Genome Center Institute of Medical Science The University of Tokyo Japan

10. Institute for the Advanced Study of Human Biology (WPI‐ASHBi) Kyoto University Kyoto Japan

11. Department of Medicine Center for Hematology and Regenerative Medicine Karolinska Institute Stockholm Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16720

Reference38 articles.

1. Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013

2. Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups

3. Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients

4. Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma

5. Genomic complexity of multiple myeloma and its clinical implications